JVLCX
Price
$23.14
Change
+$0.12 (+0.52%)
Updated
Jul 25 closing price
Net Assets
17.98B
RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

JVLCX vs RMFEX

Header iconJVLCX vs RMFEX Comparison
Open Charts JVLCX vs RMFEXBanner chart's image
JHancock Disciplined Value C
Price$23.14
Change+$0.12 (+0.52%)
VolumeN/A
Net Assets17.98B
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
JVLCX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVLCX vs. RMFEX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVLCX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. JVLCX (18B). RMFEX pays higher dividends than JVLCX: RMFEX (1.53) vs JVLCX (0.02). JVLCX was incepted earlier than RMFEX: JVLCX (17 years) vs RMFEX (23 years). JVLCX (1.72) is less costly to investors than RMFEX (0.62). JVLCX is a more actively managed with annual turnover of: 63.00 vs. RMFEX (31.00). RMFEX has a lower initial minimum investment than JVLCX: RMFEX (250) vs JVLCX (1000). RMFEX annual gain was more profitable for investors over the last year : 11.74 vs. JVLCX (-1.98). RMFEX return over 5 years is better than : 62.99 vs. JVLCX (34.82).
JVLCXRMFEXJVLCX / RMFEX
Total Expense Ratio1.710.62276%
Annual Report Gross Expense Ratio1.720.62277%
Fund Existence17 years23 years-
Gain YTD7.82211.52768%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets18B111B16%
Annual Yield % from dividends0.021.531%
Returns for 1 year-1.9811.74-17%
Returns for 3 years12.1332.0838%
Returns for 5 years34.8262.9955%
Returns for 10 years26.3988.9630%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited